Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients

被引:69
|
作者
Toussaint, Nigel D. [1 ,2 ]
Polkinghorne, Kevan R. [1 ,2 ]
Kerr, Peter G. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
关键词
arterial compliance; B-type natriuretic peptide; cardiovascular disease; exercise; hemodialysis; pulse wave velocity;
D O I
10.1111/j.1542-4758.2008.00262.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular (CV) disease is the most common cause of mortality in end-stage kidney disease (ESKD), and arterial stiffness, measured by pulse wave velocity (PWV), is an independent predictor of all-cause and CV mortality. B-type natriuretic peptide (BNP) levels are high in patients with CV disease and ESKD, and increases in BNP may also be a marker of CV risk. Regular exercise has many benefits on quality of life and physical strength and may also improve CV risk, but few studies have addressed the impact of exercise on CV risk in ESKD. We performed a prospective cross-over trial in 19 hemodialysis (HD) patients to assess the impact of regular exercise on surrogate markers of CV risk-arterial compliance and BNP levels. Exercise involved the use of a bicycle ergometer for minimum 30 min at each HD session for 3 months, with a 1-month washout period. Group A (n=9) exercised for the first 3 months only, while group B (n= 10) performed no intradialytic exercise initially and exercised for 3 months at cross-over (month 4). Pulse wave velocity was performed using a SphygmoCor device, with concurrent measurements of BNP and other serum markers, at the commencement of the study, at 3 months, and on completion. The mean PWV (A: 10.4 +/- 3.1 m/s, B: 9.8 +/- 3.8 at baseline) showed a trend toward improvement with exercise (A: 8.7 +/- 2.7, p=0.07), and no significant change without (B: 10.5 +/- 3.6, p=0.3 1). After cross-over, there was an increase in PWV in group A with cessation of exercise (9.75 +/- 2.4, p=0.01 vs. 3 months) and an improvement in group B with exercise (9.33 +/- 2.3, p=0.11 vs. 3 months). When comparing PWV after 3 months of exercise vs. 3 months of no exercise (paired t test), there was a significant difference in favor of exercise (9.04 +/- 0.59 vs. 10.16 +/- 0.74, p=0.008). The mean BNP levels following 3 months of exercise were also lower than those after 3 months of no exercise (504.4 +/- 101.2 vs. 809.4 +/- 196.1 [N <100], p=0.047). There was an overall improvement in PWV, and to a lesser extent BNP levels, with 3 months of intradialytic exercise compared with no exercise, suggesting that regular exercise in ESKD may be associated with improvements in arterial compliance and a reduction in CV risk.
引用
收藏
页码:254 / 263
页数:10
相关论文
共 50 条
  • [41] The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure
    Tabbibizar, R
    Maisel, A
    CURRENT OPINION IN CARDIOLOGY, 2002, 17 (04) : 340 - 345
  • [42] B-type natriuretic peptide in patients with clinical hyperthyroidism
    T. Wei
    C. Zeng
    Y. Tian
    Q. Chen
    L. Wang
    Journal of Endocrinological Investigation, 2005, 28 : 8 - 11
  • [43] Plasma B-type natriuretic peptide levels in cardiac donors
    Amir, Nezar L.
    Gerber, Ivor L.
    Edmond, John J.
    Langlands, Janice M.
    Richards, A. Mark
    Ruygrok, Peter N.
    CLINICAL TRANSPLANTATION, 2009, 23 (02) : 174 - 177
  • [44] B-type natriuretic peptide in patients with clinical hyperthyroidism
    Wei, T
    Zeng, C
    Tian, Y
    Chen, Q
    Wang, L
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (01) : 8 - 11
  • [45] Assessment of B-type natriuretic peptide in patients with pneumonia
    Yetkin, O.
    Hacievliyagil, S. S.
    Gunen, H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (03) : 488 - 491
  • [46] B-type natriuretic peptide predicting exercise tolerance in patients with coronary heart disease
    Grybauskiene, Regina
    Karciauskaite, Dovile
    Bertasiene, Zita
    Urbonaviciene, Grazina
    Janenaite, Jurate
    Grybauskas, Pranas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 119 : S19 - S20
  • [47] Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus
    Bhalla, MA
    Chiang, A
    Epshteyn, VA
    Kazanegra, R
    Bhalla, V
    Clopton, P
    Krishnaswamy, P
    Morrison, LK
    Chiu, A
    Gardetto, N
    Mudaliar, S
    Edelman, SV
    Henry, RR
    Maisel, AS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (05) : 1047 - 1052
  • [48] Incremental Prognostic Value of Discordant Amino Terminal Pro B-type Natriuretic Peptide Compared to B-type Natriuretic Peptide Levels in Stable Patients with Heart Failure
    Grodin, Justin L.
    Hammadah, Muhammad
    Hazen, Stanley L.
    Tang, W. H. W.
    CIRCULATION, 2014, 130
  • [49] B-type natriuretic peptide and arterial stiffness in healthy Japanese men
    Yambe, M
    Tomiyama, H
    Koji, Y
    Motobe, K
    Shiina, K
    Gulnisia, Z
    Yamamoto, Y
    Yamashina, A
    AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (05) : 443 - 447
  • [50] Modulation of B-type natriuretic peptide with epoprostenol in pulmonary arterial hypertension
    Park, MH
    Scott, RL
    Uber, PA
    Ventura, HO
    Tannehill, CC
    Mehra, MR
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S45 - S45